BB BIOTECH AG - ENDOCYTE INC ownership

ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 102 filers reported holding ENDOCYTE INC in Q2 2014. The put-call ratio across all filers is 4.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
BB BIOTECH AG ownership history of ENDOCYTE INC
ValueSharesWeighting
Q3 2014$4,156,000
-74.4%
683,522
-72.3%
0.17%
-78.1%
Q2 2014$16,235,000
-72.3%
2,463,5220.0%0.77%
-74.5%
Q1 2014$58,656,000
+107.8%
2,463,522
-6.8%
3.02%
+100.5%
Q4 2013$28,233,000
-6.7%
2,643,522
+16.5%
1.51%
-8.4%
Q3 2013$30,250,000
-1.5%
2,269,345
-3.0%
1.65%
-25.6%
Q2 2013$30,716,0002,339,3452.21%
Other shareholders
ENDOCYTE INC shareholders Q2 2014
NameSharesValueWeighting ↓
Corbenic Partners LLC 30,639$95,0000.10%
Leisure Capital Management 29,655$92,0000.09%
Cribstone Capital Management, LLC 32,541$101,0000.08%
HIGHLAND CAPITAL MANAGEMENT LP 442,656$1,372,0000.06%
PINNACLE ASSOCIATES LTD 898,096$2,784,0000.06%
Bellevue Group AG 100,000$310,0000.06%
Baker Brothers Advisors 1,695,865$5,257,0000.06%
Curi RMB Capital, LLC 217,885$675,0000.04%
Spark Investment Management LLC 116,300$360,0000.04%
OXFORD ASSET MANAGEMENT LLP 244,192$757,0000.02%
View complete list of ENDOCYTE INC shareholders